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1. Introduction 
Pramateftakis MG 
Worldwide, colorectal cancer is a major health problem. More than 1 million patients are 
diagnosed annually. It is the 3rd most common cancer type and about half a million people 
die of the disease each year. Incidence is higher in more developed than less developed 
regions suggesting that lifestyle, dietary habits and environmental exposures, beyond 
genetic background, are responsible for the disease in the industrialized world.  
In recent years significant knowledge has been acquired and applied in everyday clinical 
practice as far as rectal cancer is concerned. The treatment of rectal cancer has changed over 
the last two decades as far as surgical techniques, chemotherapy and radiotherapy are 
concerned. Effective surgery and modern radiotherapy combined with cytotoxic 
chemotherapy have improved survival rates (Nicholls & Tekkis, 2008; Carlsen et al., 1998). 
2. Rectal cancer staging 
Pramateftakis MG, Papadopoulos V, Michalopoulos A 
The assessment of a patient with rectal cancer involves the identification of disseminated 
disease and the locoregional staging of the tumor. Loco-regional factors which influence 
prognosis include T-stage, the lymph node status and the histological grade. Rectal cancer 
presents in 3 clinical categories. These are the early, the intermediate and the advanced lesions. 
The improvement of conventional diagnosis and the introduction of molecular screening 
advanced early diagnosis. Virtual colonoscopy, computed tomography (CT), magnetic 
resonance imaging (MRI), endorectal ultrasound (EUS) and positron emission tomography 
(PET) constitute a significant development to the diagnosis and staging of colorectal cancer 
(Kuhry et al, 2008). Endorectal ultrasound can demonstrate penetration of the rectal wall 
with high accuracy, but is poor at identifying the N stage. CT is useful for local extensive 
tumors particularly in identifying other organ involvement. MRI is accurate in determining 
the T stage but performs better in identifying the presence or absence of the circumferential 
margin involvement. In the last five years, preoperative staging has become more refined by 
advances in MRI imaging. 
EUS seems to be an accurate method to stage rectal cancer preoperatively. The major 
drawback of EUS is that it is operator-dependent, but on the other hand it is easy and fast to 
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perform, requires minimal patient preparation and it can be repeated without side effects. 
EUS based evaluation of rectal tumors provides an accuracy ranging from 62% to 92% for T 
staging and from 64% to 88% for N staging (Kim & Wong, 2005). 
Pelvic CT staging of rectal cancer is inferior to EUS with the accuracy for T staging ranging 
from 53% to 94% and for N staging from 54% to 70% (Harewood, 2005). MRI, especially with 
the use of endorectal coil, seems to be superior to CT for locoregional rectal cancer staging, 
with accuracy for T staging ranging from 66% to 92% and that for N staging rising over 95% 
(Chen et al., 2005). 
A recent meta-analysis showed that EUS and MRI had similar sensitivity for T staging (94%) 
but EUS had superior specificity compared to MRI (86% vs 69%). This study also showed 
that both EUS and MRI have poor sensitivity (67%) and specificity (77%) for N staging. 
However, there are reports in the literature stating that EUS may be overestimated, 
especially in small size series. Therefore, it seems that the accuracy of imaging methods for 
the N stage of rectal cancer needs further improvement (Harewood, 2005; Kwok et al., 2000). 
PET scanning has been used preoperatively to rule out metastatic disease in selected cases 
and postoperatively for the detection of recurrence or to evaluate response to treatment. It is 
reported that PET scan alters the conventional preoperative stage in nearly 40% of cases 
leading to modification of therapeutic strategies in 17% of patients. Furthermore, there is 
evidence that PET is more sensitive than CT for the evaluation of the response to 
neoadjuvant treatment, able in some cases to ‘predict’ pathologic response. Currently, there 
are no large series with regards to the initial locoregional staging of rectal tumors using PET 
and the significance of this method is mainly identified in neoadjuvant protocols (Heriot et 
al., 2004). 
 
 
Fig. 1. Rectal mass identified on CT scan. Metastatic lymphnodes at the inferior mesenteric 
artery root. 
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3. Surgical approach to rectal cancer 
Pramateftakis MG, Tsoulfas G 
After the diagnosis and staging of a rectal tumor, a decision needs to be made with regards 
to the optimal method of surgical treatment. To save or not to save the sphincters is a 
common question. Is there a level below which an anastomosis should not be attempted? 
The optimal surgical technique for low rectal tumors remains controversial in the absence of 
randomized trials. Conversely, too often, in a fanatic effort to avoid a colostomy and to 
reestablish intestinal continuity, surgeons compromise on the margins of resection. The 
consequences are often tragic for the patient (recurrence, anastomotic obstruction, functional 
problems and pelvic pain). 
The intention of oncologic surgery for rectal cancer is the removal of the primary tumour 
and regional lymphatics and the prevention of tumour cell spillage. Controversy still exists 
about the extent of lymphadenectomy, the importance of the Turnbull’s no touch technique, 
the optimal free distal margin and the irrigation of the rectal stump. Whether complete 
retroperitoneal clearance of all lymphatic tissue (“pre-aortic strip”) offers advantage to 
survival rates is still doubtful. There are no randomised clinical trials supporting the value 
of extended lateral internal iliac lymph node excision. Moreover, there is a high incidence of 
urinary and sexual complications because of autonomic nerve damage (Pramateftakis et al., 
2010). 
In 1981, Heald introduced the concept of total excision of the mesorectal adipose and 
lymphatic tissue for middle and lower rectal carcinomas, namely the Total Mesorectal 
Excision (TME). Apart from the TME, oncologic resection involves the mobilization of the 
splenic flexure, high ligation of the inferior mesenteric artery (IMA) and the sharp dissection 
under direct vision of the mesorectal tissues to the level of the levators. The fascia propria of 
the mesorectum and the nerve plexus must be preserved intact, leaving a smooth mesorectal 
surface. The middle rectal vessels must be cauterized. With this technique, all the lymphatic 
tissue surrounding the rectum is removed. The specimen may contain the tumor tissue, its 
intraluminal extent, the metastatic infiltrated lymph nodes, vessels and nodules. TME is 
now considered to be the ‘gold standard’ approach for the middle and low rectal cancers 
(Heald, 1982, 1992). 
Hospital patients’ volume seems to have an impact on colostomy rates, postoperative 
mortality and overall survival. In a series of 7257 patients diagnosed with Stage I–III rectal 
cancer between 1994 and 1997, there were statistically significant differences in colostomy 
rates (29.5% versus 36.6%), 30-day postoperative mortality (1.6% versus 4.8%) and in overall 
2-year survival (83.7% versus 76.6%) in hospitals with higher patient volumes (>20 
procedures per year) compared to those with fewer than 7 procedures annually. The ability 
for sphincter-sparing surgery is also affected by the hospital volume. In an adjuvant 
treatment trial of 1330 patients with Stage II or III rectal cancer, the rates of abdoperineal 
resections as opposed to low anterior resections were significantly higher in low-volume 
hospitals (46% versus 32%, respectively) (Meyerhardt et al., 2004). 
The type of operation that can be offered to a patient with rectal cancer depends not only on 
tumour stage, but also on the location of the tumour in relation to the surgical anatomy. 
Surgical anatomy refers to the anatomic landmarks that determine resectability and 
sphincter preservation. The NCI consensus on rectal cancer recommended localizing the 
tumour relation to the anal verge, which is defined as starting at the intersphincteric groove. 
Another important landmark defining the upper limit of the anal canal is the anorectal ring. 
www.intechopen.com
 
Advances in Cancer Management 
 
60
From the surgeon’s perspective, the top of the anorectal ring is the lower limit of a distal 
resection margin. A large, full-thickness cancer needs to be located high enough above the 
top of the anorectal ring to allow for an adequate distal margin if sphincter preservation is 
contemplated. If the dissection is to be carried lower towards the dentate line, then the 
tumor must be confined to the mucosa, submucosa, and superficial layer of the internal 
sphincter (Bleday & Garcia-Aguilar, 2007). 
Quality surgery and adjuvant therapy have improved overall 5-year survival rates for 
colorectal cancer over the last decades. It is nowadays proven that a sphincter-sparing 
surgical approach does not sacrifice survival in selected patients when an adequate margin 
can be achieved (Bleday & Garcia-Aguilar, 2007). 
In summary, aim of the technique chosen is the regional disease control, the radical tumor 
resection (R0) and the preservation of the sphincter mechanism (whenever possible). 
Therefore, depending on the tumor location, the surgical choices are the low anterior 
resection, the intersphincteric resection, the transanal resection and the abdominoperineal 
resection. All approaches will be discussed in detail in the following paragraphs. 
 
 
Fig. 2. Low anterior resection specimen with high ligation of the feeding vessels (IMA). 
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4. Low anterior resection for rectal cancer 
Michalopoulos A, Papadopoulos V, Pramateftakis MG 
A low anterior resection is undertaken in order to remove malignant tumors of the middle 
and lower rectum. For the radical excision of a rectal cancer, a “5-cm rule” distal free margin 
below the tumor has been an important issue. However, intramural spread exceeds 1–2 cm 
in a few occasions only and further increase of the distal margin beyond 2 cm does not 
improve the locoregional recurrence rate or survival. An established principle is that the 
mesorectum and the wall of the rectum should be transected at the same level (Williams et 
al., 1983). The resection concerns the intra- and extraperitoneal rectosigmoid and the 
anastomosis is conducted below the peritoneal reflection (<8 cm from the anal ring). The 
anastomosis is performed either manually (usually in an end-to-end manner) or by the use 
of automatic stapling devices, in which case it can be performed as an end-to-end, end-to-
side or side-to-side anastomosis. 
4.1 Technical considerations & controversies 
4.1.1 Low anterior resection and coloanal anastomosis 
In case of a very low anterior resection, the anastomosis is performed at the level of the 
dentate line, after excision of the upper half of the internal sphincter. The direct end-to-end 
anastomosis is performed either transanally, or by the York Mason technique, the Kraske 
technique, or even by the use of a circular stapler. A diverting ileostomy should also be 
performed (Pramateftakis et al., 2010).  
4.1.2 Coloanal anastomosis with colonic J-pouch 
A colonic J-pouch is recommended for carcinomas of the middle and lower rectum, large 
benign tumors of the lower rectum, heavy radiation orthitis and rectal Crohn’s disease.  
Contraindications for a J-pouch include the infiltration of the levator muscles by the tumor, 
inflammation and fistulas of the perineum and anal incontinence.  
The rectal cancer excision is similar to the traditional very low anterior resection, with the 
addition of a colonic J-pouch construction. The descending colon is preferred to the sigmoid 
colon, because it is firmer and has better adaptability. For the safety of the low anastomosis, 
the operation must be supplemented by the creation of a temporary ileostomy, which is 
usually reversed after 2-3 months. Patients with a pouch have fewer stool evacuations per 
day, but some of them may need enemas or suppositories to evacuate. However, the 
anastomosis is considered safer and there is a lower incidence of the post-operative low 
anterior resection syndrome, nevertheless only in the early postoperative period. During the 
late postoperative period, there are no statistically significant advantages of a colonic J-
pouch when compared to the simple coloanal anastomosis, as the intestine gradually seems 
to adapt (Jeng-Kai et al, 2005; Nicholls, 1991). 
4.1.3 Low Colorectal anastomosis with ileocecal reservoir transposition 
An alternative method of a colonic reservoir after a low anterior resection is the ileocecal 
transfer, in cases of inadequate left colic flexure mobilization. The cecum, along with the 
final part of the ileum and their blood supply (ileocolic artery) are transferred to the rectal 
stump. In this case, the cecum is used as a pouch, with the added effect of a valve 
mechanism (ileocecal valve) (Jeng-Kai et al., 2005). 
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4.1.4 Pull-through (coloanal anastomosis)  
After removing the rectum, the anus is dilated and, using stay sutures to the rim of the 
rectal stump, the anus or the rectal stump is reversed and is delivered out of the anal ring, 
with the mucosa facing outwards. Then, through the inverted rectal stump, the sigmoid or 
the descending colon is pulled out for about 10 cm and the anastomosis is performed. 
Alternatively, a catheter can be placed into the sigmoid colon and the excessive intestine 
is excised 2 weeks later, after mucosal approximation with absorbable sutures (Bennett, 
1986). 
4.1.5 Total Mesorectal Excision (TME) 
The posterior wall of the mesorectum is covered by the fascia propria, which is a part of the 
visceral fascia. The sacrum and the coccyx are covered by a strong aponeurotic fascia, which 
represents the continuation of Todd’s fascia. The fascia of Waldayer is a thickening of this 
pelvic aponeurotic fascia and connects the rectal fascia to the pelvic sacral fascia. In the 
middle of the anterior wall, the rectum receives a reflection from the peritoneum of the 
posterior wall of the bladder in men or the uterus in women, creating the Douglas pouch, at 
a distance of 7-9 cm from the anus. This is usually deeper in women and divides the rectum 
in an intraperitoneal, covered by serosa in the front and sides and an extraperitoneal part, 
not covered by serosa, but by a thin layer of the visceral fascia, called Denonvillier’s fascia 
(Heald, 1982). 
The rectum is devoid of mesentery, but the fascia propria covers the lymphatic tissue and 
the lymphnodes of the rectum, the upper and mid rectal vessels, and lipoid tissue forming 
the “Mesorectum”. The resection of the rectum and mesorectum with the lymph nodes and 
the preservation of the neural plexus is called a “total mesorectal excision” (TME). A 
correctly performed TME avoids complications from the urogenital system and the 
sphincters, since it does not damage the autonomic nerve plexus. Key step of the procedure 
is the identification and preservation of the pre-aortic superior sympathetic hypogastric 
plexus and the laterally located hypogastric nerves and sacral splanchnic nerves, forming 
the inferior hypogastric plexus (sympathetic-parasympathetic nerves S2-S4) on both sides of 
the pelvic wall. Intact nerves should look like a “fishbone” near the sacral promontory, after 
a proper dissection (Miles, 1971). 
TME is currently recommended for distal mid- and lower rectal cancers, with complete 
excision of the visceral mesorectal tissue, down to the level of the levators. For upper third 
or rectosigmoid cancers a tumour specific mesorectal excision (TSME) should be preferred, 
performing perpendicular and circumferential excision of the mesorectum to a resection 
margin level of 5 cm distal to the tumour (Wibe et al., 2002). 
4.1.6 Extent of distal resection margin for rectal cancer 
Even though the intraluminal spread of colorectal cancer is accomplished through the 
lymphatics of the submucosa or those of the perirectal fat, the mucosal cancer spread rarely 
extends beyond the 4 cm, distally. In well differentiated, very low carcinomas a distal 
margin of 2 cm is considered satisfactory, since the 98% of tumour dispersion is in a distance 
less than 2 cm. This necessitates the preoperative identification of the degree of tumor cell 
differentiation and the proper measurement of the distal margin in the fresh specimen by 
the surgeon (Heald, 1982; Wibe et al., 2002). 
www.intechopen.com
 
Rectal Cancer - Staging and Surgical Approach 
 
63 
4.1.7 High ligation of the inferior mesenteric artery (IMA) 
High ligation of the inferior mesenteric artery is mandatory. The dissection and ligation of 
the IMA 1cm from the aorta, preserves the superior hypogastric plexus, formed by fibres of 
the sympathetic ganglia of the prevertebral sympathetic chain. In a study by Hohenberger et 
al, 14 patients with local recurrence after ‘radical excision’ of rectal carcinomas underwent a 
selective angiography of the inferior mesenteric artery. The remaining stamp of the IMA 
was found to be longer than 1cm in 11 cases (79%). Some authors report a 5-year survival 
improvement by 5,7% following a high IMA ligation, while others found no improvement in 
survival even in patients of stage Dukes C (Hohenberger et al., 1991). 
4.1.8 Extensive lymphatic clearance 
Extensive lymphatic dissection includes the excision of tissues and lymph nodes 
surrounding the aorta and iliac vessels reaching proximally to the duodenum, distally to the 
levator muscles and laterally to the ureters. It also includes the TME, the dissection of the 
thyroid spaces and the possible ligation of one of the internal iliac vessels. Even though 5-
year survival is reported to increase from 2.3% to 10.4% after extensive lymph node 
dissection, this approach is accompanied by higher morbidity and increased risk of 
complications, such as damage to the ureters and cystic or sexual dysfunction (McDermott 
et al, 1982). 
4.1.9 No-Touch Technique 
This technique involves the early ligation of the inferior mesenteric vessels (first the inferior 
mesenteric vein distally to the lower border of the pancreas followed by the inferior 
mesenteric artery, flat to the aorta), before any handling of the tumor finds place. Following 
the vessel ligation, the colonic lumen is isolated proximally and distally to the cancer. In this 
way, the spillage of cancer cells during the operating manoeuvres is avoided. 
Particularly for the rectal carcinoma, the intraluminal cancer cells apoptosis, spillage and 
implantation of tumour cells are considered to be important for the increase of the cancer 
relapses across the stapled line, following a low anterior excision. The technique of early 
luminal occlusion with a clamp or a rectal stapler distally, followed by complete TME and 
the intrarectal wash out with antiseptics and cytotoxic solutions, appears to reduce the local 
recurrences (Young-Fadok et al., 1998). However, in a randomized, prospective study by 
Wiggers et al., there was no significant difference in the 5-year survival rate between the two 
techniques (Wiggers et al., 1988). 
4.1.10 Oophorectomy 
The incidence of synchronous metastases to the ovaries in case of colon cancer is 2-8%. 
Colorectal carcinomas metastasize to the ovaries either by direct implantation or by 
lymphatic and haematogenous metastases, due to the pelvic lymphatics. Ovarian metastases 
seem to appear more frequently in postmenopausal women, while at the same time the risk 
of developing primary ovarian malignancy is referred to be 5 times higher when compared 
to the general population. However, prophylactic oophorectomy does not appear to offer 
any benefits to all colorectal cancer patients, because the risk of occult microscopic disease 
seems to be low (Young-Fadok et al., 1998). Bilateral oophorectomy is advised when one or 
both ovaries are grossly abnormal or involved with contiguous extension over the colon 
cancer. However, prophylactic oophorectomy is not recommended. (Level of Evidence Class 
II, Grade B) (Otchy et al., 2004). 
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4.2 Early complications following low anterior resection 
4.2.1 Bleeding 
Intraoperative bleeding is usually due to inadequate preparation of the rectal stump, an 
error in the performance of the purse string suture, poor haemostasis of the mesorectum, 
inadequate vascular ligations or a presacral plexus injury. Endo-rectal bleeding is 
considered to be due to the shape of the clips, forming a ''B'' after their closure and allowing 
gaps through which bleeding can occur. Bleeding may also be due to the capture of foreign 
tissue inside the circular stapler, such as the prostate and the vagina (Nesbakken et al., 
2002). 
4.2.2 Anastomotic leakage 
Anastomotic dehiscence occurs more commonly in rectal and oesophageal anastomoses 
than in other parts of the alimentary tract. The main reasons are technical difficulties in 
dissection of these organs and their easily compromised blood supply. Leakage following a 
low anterior resection can cause a faecal fistula, pelvic peritonitis or generalized peritonitis. 
Subclinical leaks are often reported when a postoperative radiologic control is conducted 
(Kanellos I et al., 2004). 
Systematic protective colostomy or ileostomy does not prevent the occurrence of the 
complication, but limits its consequences, as well as the postoperative hospitalization time. 
Elderly patients may develop delayed leakages, due to slower healing capabilities (Bittorf et 
al., 2003; Demetriades et al., 2004). 
Anastomoses located 3 to 6 cm from the anal verge may lead to leak rates up to 17%. Some 
centres are now routinely fashioning a ‘protective’ diverting stoma. In a randomized 
multicentre trial, the overall rate of symptomatic leakage was reported to be 19.2%. Patients 
who had a defunctioning stoma had an anastomotic leakage at 10.3% of the cases and those 
without a stoma had leakage rates of 28% (p≤ 0.001). The necessity for an urgent re-
operation was 8.6% in patients with a protective stoma and 25.4% in those without one 
(p≤0.001) (Matthiesen et al., 2007; Vrakas et al., 2010). 
In another study comparing laparoscopic vs open TME, intestinal obstruction occurred in 5 
cases in the laparoscopic group and in 3 cases in the open group. In the laparoscopic group, 
intestinal obstruction was in the majority of the cases (60%) caused by a problem at the 
ileostomy site. As a consequence, the loop ileostomy was abandoned as a mode of diversion 
in favour of the use of a loop transverse colostomy (Staudacher et al., 2007). 
Whether a loop ileostomy or a loop colostomy is a better form of faecal diversion remains 
controversial. Two randomized studies that compare the two techniques and included only 
patients who had elective TME for rectal cancer reported controversial results. Nevertheless, 
a trend towards a higher anastomotic leak rate has been observed in patients in whom a 
stoma was not fashioned at the primary operation. Therefore, many surgeons who perform 
TME have now the policy to temporarily defunction almost all low anastomoses (Law et al., 
2002; Rullier et al., 2003; Staudacher et al., 2007). 
Subclinical (meaning non-symptomatic) anastomotic failure may occur in up to 51% of 
patients, associated with mortality rates ranging from 6% to 22%. Branagan & Finnis 
reported a 30-day mortality rate of 10% (Branagan & Finnis, 2005). Ptok et al found that 
patients with anastomotic leakage had a higher rate of immediate postoperative 
complications (50.8% vs 26.5%, p≤ 0.001) and longer hospital stay (29 vs 15 days, p≤ 0.001) 
(Ptok et al., 2007). Taflampas et al reported that male sex, smoking, alcohol abuse and 
preoperative malnutrition are all risk factors for anastomotic leakage. They also concluded 
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that the distance of the anastomosis from the anal verge has a significant impact on 
anastomotic failure rates. They recommend the routine mobilisation of the splenic flexure 
and anastomosis of the descending colon, instead of the sigmoid, to the rectal stump 
(Taflampas et al., 2009). 
The use of a colonic J-pouch seems to decrease the leakage rates after low anterior resection. 
The size and stage of the primary tumor, the type of the anastomosis (stapled or hand-
sewn), omentoplasty, extraperitoneal positioning of the anastomosis, bowel preparation, the 
use of laparoscopy and the use of a pelvic drain do not reduce the leakage rates. The short 
scheme of radiotherapy is also not considered to be a significant risk factor. Collagen type 
and enzyme expression of the tissues, blood transfusions and the learning curve associated 
with the use of staplers are factors whose association and importance on anastomotic 
leakage is not yet clarified (Taflampas et al., 2009). 
It is uncertain whether the long scheme of radiotherapy or the addition of chemotherapy 
increases the anastomotic leakage rate. The value of creating a protective stoma is debatable. 
It may be indicated for anastomoses lower than 6 cm from the anal verge, even though some 
suggest its elective use (Taflampas et al., 2009). 
4.3 Late complications following low anterior resection 
4.3.1 Anastomotic stricture 
A stricture of the anastomosis is defined as the difficulty of passing the 19mm rectoscope 
through it. Possible reasons considered are reactive fibrosis to a foreign body (clips), or the 
consequence of a subclinical leakage. The first possibility is unlikely, while the latter is in 
contrast to the fact that since there are statistically more subclinical leakages in hand sewn 
coloanal anastomoses, they should therefore display more frequently strictures than the 
stapled ones; something that does not happen. 
Other causes of strictures are ischemia caused by excessive devascularisation of the rectal 
stump and the use of small calibre staples (<28mm). Defunctioning colostomies are also 
thought to provoke strictures because of regression in the diameter of the distal colon (Rees 
et al., 2004). 
4.3.2 Rectovaginal fistula 
Rectovaginal fistulae may be a consequence of radiation therapy preceding or following rectal 
surgery, of inflammatory bowel diseases, such as ulcerative colitis and especially Crohn’s 
disease, or as a complication following improper firing of the stapler. When creating a stapled 
anastomosis, the accidental capture of vaginal wall between the main body and the anvil of the 
stapler results in the creation of a rectovaginal fistula. Other causes for fistula creation are 
subclinical anastomotic dehiscence, haematoma, ischemia, or abscess. Incomplete or excessive 
rectal stump devascularisation can also lead to a rectovaginal fistula formation. 
In cases of a fistula because of cancer recurrence, a lower anterior resection, or an 
abdominoperineal resection must be performed. 
In other cases, a diverting colostomy may initially be conducted followed by a restorative 
operation at a later stage (transvaginal or transanal). Adhesive substances for eliminating 
the fistula have also been tried, with controversial results (Sugarbaker, 1996). 
4.3.3 Urinary and sexual dysfunction 
Postoperative impotence and/or retrograde ejaculation have been observed in 25%–75% of 
cases, particularly when lateral wall lymphadenectomy and splanchnic nerve resection are 
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performed. In contrary, when TME with careful nerve-sparing dissection is performed, 
impotence occurs in only 10%–29% of cases (Bleday, 2007). Nevertheless, excessive 
dissection during TME may also lead to sexual dysfunction. During the dissection of the 
rectum inside the pelvis, the so called “lateral ligaments” should not be clamped and 
ligated, but cauterized instead. These ligaments contain small nerve branches of the inferior 
hypogastric plexus and minor vessels arising from the branches of the internal iliac artery, 
which pass to the mesorectum. These plexuses can be damaged by dissection and clamping. 
Great care also has to be taken during the lateral dissection of the Denonvillier’s fascia, 
where the neurovascular bundle of Walsh rises from the inferior hypogastric plexus. That 
bundle runs along the posterolateral aspect of the prostate. 
The clinical consequence of an isolated sympathetic nerve injury is retrograde ejaculation. 
Dissection beneath the presacral or pelvic fascia from the sacral promontory around to the 
lateral pelvic sidewall can injure both parasympathetic and sympathetic nerve fibres which 
can result in impotence and bladder dysfunction (Nesbakken et al., 2002). 
4.3.4 Incontinence 
It may be due to a disorder in the sensation for faecal evacuation (due to the rectal excision), 
damage to the pudendal nerves, destruction of nerve plexuses or damage to the sphincter 
mechanism (Bittorf et al., 2003; Rasmussen et al., 2003). 
4.3.5 Post-operative low anterior resection syndrome 
The low anterior resection syndrome characterizes the disturbance in the perception of 
continence of various degrees, the quality and frequency of evacuation, urgency, tenesmus, 
urinary and sexual dysfunction following a low anterior resection of the rectosigmoid. 
Continence, as well as normal bowel evacuation, is due to the integrity of sensory, motor 
and central nervous functions and anatomic formations (hypogastric plexuses, pudendal 
nerves, tension receptors of the pelvic floor etc.) Furthermore, the knowledge and 
acceptance of the coordination mechanism of continence and defecation (constipation, 
incontinence, continence and biofeedback and re-education) plays an important role. 
Incontinence is due to:  
a. Disorders of the rectal reservoir, eg. because of chronic inflammation (Crohn’s disease, 
ulcerative colitis, radiation) or because of a very low anterior resection 
b. Neurologic disorders, eg. damage of the CNS (CNS or spine injury), sensory receptor 
damage (Whitehead operation, pull-through excision) or damage to the motor 
transmission (perineal descent syndrome, age, childbirth) 
c. Muscle damage, eg. due to sphincteric lesions (fistulas, episiotomy, accidents) 
d. The low anterior resection syndrome (Rasmussen et al., 2003; Matzel et al., 2003) 
Theories that have been reported to be associated with the low anterior resection syndrome 
are: 
i. Theory of loss of the rectal pouch. 
ii. Theory of loss of anal sensation. 
iii. Theory of damage to the internal anal sphincter. 
iv. Theory of the proximal intestine’s lumen diameter (Lumen score, r2). 
v. Theory of sympathetic denervation (Rasmussen et al., 2003). 
The Low Anterior Resection Syndrome is a multi-factorial condition (sympathetic 
denervation, rectal pouch capacity loss, sphincteric damage, colonic motility disorders and 
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patient’s psychopathology). Improvement is expected at 6 months after the operation, while 
the CNS may act unpredictably. The J-pouch construction is controversial and chemo-
radiotherapy increases the degree of incontinence. Prognostic factors for the possibility of 
occurrence of post-operative incontinence are anal sensitivity testing, manometry, radiologic 
data and anorectal endosonography. However, the preservation of the nervic plexuses may 
contribute in minimizing the consequences of the Low Anterior Resection Syndrome. Low 
anterior resection may cause some degree of incontinence in 15-30%, but regardless of that, 
70% of the patients are fully and 14% partially satisfied, post-operatively (Matzel et al., 2003; 
Rasmussen et al., 2003). 
4.4 Local recurrence and survival after low anterior resection; the importance of TME 
Total mesorectal excision rapidly became the “gold standard” for anterior resection of the 
rectum and a marked reduction of local recurrence rates has been seen. It is reported that the 
locoregional recurrence rate at 4 years by conventional techniques is 12-32%, in contrast to 6-
9% following TME (Wibe et al., 2002). 
Data from a randomized, prospective trial by the National Surgical Adjuvant Breast and 
Bowel Project, demonstrated no significant differences in survival or local recurrence when 
comparing distal rectal margins of <2cm, 2–2.9 cm and >3 cm (Heriot et al., 2006; Saito et al., 
2009). As a result, a 2-cm distal margin is considered acceptable for resection of rectal 
carcinoma; even though a 5-cm proximal margin is still recommended for upper rectal 
cancers. The radial margin seems to be critical for local control. Macroscopic pathologic 
characteristics of completeness of mesorectal excision are (Vordermark et al., 1989):  
Incomplete excision: Little bulk to the mesorectum 
   Defects in the mesorectum up to the muscularis propria 
   Very irregular circumferential margin at transverse sectioning  
Nearly complete excision:  Moderate bulk to the mesorectum 
   Irregularity of the mesorectal surface with defects greater than 5 
   mm, but not up to the muscularis propria 
   No area of visibility of the muscularis propria  
Complete excision: Intact bulk to the mesorectum with a smooth surface 
   Only minor irregularities of mesorectal surface 
   No surface defects greater than 5 mm in depth 
   No ‘coning’ of the distal mesorectum 
   Smooth circumferential margin at transverse sectioning 
Local recurrence may result from an incomplete radial or circumferential margin. About 25% 
of cases may have unsuspected involvement of the radial margin after rectal excision, which 
may result in local recurrence from an incomplete radial resection rather than from an 
incomplete distal mesorectal excision. A positive circumferential (radial or lateral) margin 
increases the risk of local recurrence 3.5 times and doubles the risk of disease-related death. 
Completeness of the mesorectum in the specimen predicts both local recurrence and distant 
metastases. The mesorectal surface must be marked with ink before formalin fixation. 
Assessment of the distance between the tumor and the nearest radial margin is mandatory. 
Circumferential margin is scored as positive if the tumour is located 1 mm or less from the 
inked non-peritonealised surface of the specimen (Compton et al., 2000; Wibe et al., 2002).  
The distance of the tumour from the proximal and distal margins should also be assessed in 
millimetres. Anastomotic recurrences are rare when this distance is ≥5 cm. For a lower rectal 
cancer, a 2 cm margin is considered adequate (Compton et al., 2000). 
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The R-classification indicates the completeness of a surgical excision, depending to a large 
part on the radial margin. R0 suggests complete tumor resection with all margins negative, 
R1 is an incomplete tumor resection with microscopic margin involvement and R2 is an 
incomplete tumor resection with macroscopic involvement of a margin and gross residual 
tumor. 
Total mesorectal excision may reduce local recurrence rates from 20-30% to 8-10% or less, 
and may increase 5-year survival rates from 48% to 68%. There is strong evidence that sharp 
dissection under full visualisation is superior to a blunt and partly blind dissection 
technique and that one should avoid entering into the wrong dissection plane, keeping the 
fascial envelope intact (Compton et al., 2000). 
 
 
Fig. 3. TME on rectal resection specimen. 
5. Intersphincteric resection for rectal cancer 
Spanos K, Pramateftakis MG, Tepetes K 
For technical and oncological reasons, the standard surgical treatment in very low rectal 
cancers is the abdominoperineal resection. Nevertheless, in recent years, intersphincteric 
resection (ISR) has been proposed to offer sphincter preservation in patients with such low 
lesions (Chamlou et al., 2007). 
The principle of the ISR technique is based on an anatomic dissection plane between the 
internal anal sphincter (IAS) and the external anal sphincter (EAS). The technique 
incorporates a combined abdominal and perineal approach. During ISR, a transanal division 
of the rectum, with removal of part or the entire IAS is performed after TME, thus obtaining 
an adequate distal margin. Restoration of bowel continuity is achieved by performing a 
hand-sewn coloanal anastomosis. For tumors less than 3 cm from the dentate line, an ISR 
may be performed (Chamlou et al., 2007). 
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5.1 Indications 
Inclusion criteria for performance of ISR include the following: 
- Local spread restricted to the rectal wall or the IAS. 
- Adequate sphincter function and continence. 
- Absence of distant metastases. 
- Distal margin potential of 2 cm for T2, T3 tumors. 
- Distal margin potential of 1 cm for T1 tumors 
Contraindications to the performance of ISR are the presence of fecal incontinence, T4 
lesions, undifferentiated tumors, as well as tumors invading the puborectalis and the EAS. 
The extent of local disease can be assessed with the use of MRI and/or endorectal 
ultrasound. Such studies greatly assist in selecting patients for performance of ISR. Patients 
with T1 and T2 lesions usually undergo ISR alone. For patients with T3 tumors and T2 
tumors with IAS infiltration, neo-adjuvant radio-chemotherapy is recommended (Rullier et 
al., 2005; Yamada et al., 2009). 
5.2 Short-term adverse events 
The overall operative mortality associated with ISR is 1.6% and the anastomotic leak rate 
10.5% (range 0-48%). Anastomotic stricture is reported at 5.8%. 
Rates of clinically apparent anastomotic leakage following stapled anastomosis after 
anterior resection are in the range of 3-15%. Leakage rates rise significantly for more distally 
sited anastomoses. Anastomotic leakage is associated with postoperative anastomotic 
stricture, cancer recurrence, poor postoperative function as well as increased operative 
mortality. ISR can be performed with acceptable rates of anastomotic leakage and low 
operative mortality (Rullier et al., 1998; Tilney & Tekkis, 2007). 
5.3 Oncologic outcomes 
Radical surgical removal of the tumor is the only chance for permanent cure of rectal cancer, 
despite all progress in the development of oncologic therapy. Rullier et al reported a local 
recurrence rate of 2% in their series of 92 patients undergoing ISR (Rullier et al., 2005). Most 
patients (78%) had T3 lesions and 88% underwent long-course neo-adjuvant 
radiochemotherapy. The overall 5-year survival rate was 81%, with a 5-year disease-free 
survival of 70%. 
Yamada et al reported a similarly low 2.5% cumulative 5-year local recurrence rate, a 5-year 
disease-free survival rate of 83.5% for stage II patients and 72% for stage III patients 
(Yamada et al., 2009). 
Tilney and Tekkis performed a literature search to identify studies reporting outcomes 
following ISR. Twenty-one studies accumulating a total of 612 patients were identified 
(Tilney & Tekkis, 2007). The pooled rate of local recurrence was 9.5% with an average 5-year 
survival of 81.5%. Distant metastases occured in 9.3%. 
Rates of local recurrence following low anterior resection for the treatment of rectal cancer 
are commonly reported in the range of 2.6-32% following surgery alone (Heriot et al., 2006). 
Preoperative chemoradiation therapy has led to local recurrence rates in the 6% range. 
Therefore, the performance of ISR for the treatment of very low rectal cancer affords similar 
oncologic outcomes to those of conventional resections. Moreover, Saito compared 
outcomes of patients undergoing ISR with patients undergoing abdoperineal resection 
(APR). Similar local recurrence rates (ISR=10.6%, APR=15.7%, p=non-significant), and 5-
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year disease-free survival (ISR=69.1%, APR=63.3%, p=non-significant) were reported (Saito 
et al., 2009). Patients undergoing ISR had significantly longer 5-year overall survival 
compared to patients undergoing APR (ISR=80%, APR=61.5%, p<0.05). As a conclusion, 
local and distant oncologic outcomes are not compromised with ISR. It is considered that the 
risk of local recurrence is more likely due to circumferential margin involvement than to 
distal margin involvement. 
 
 
Fig. 4. Intersphincteric resection of low rectal cancer. 
Risk factors for local and distant recurrence after ISR were reported by Akasu et al. Local 
recurrence rate was 6.7% and distant recurrence was 13% (Akasu et al., 2008). In the 
multivariate analysis, risk factors for local recurrence included positive microscopic 
resection margins, focal differentiation of tumor (tumor budding) and elevated preoperative 
levels of CA 19-9 (> 37 U/ml). The identified risk factors for distant recurrence were pN1 & 
pN2 disease, poor differentiation and the distance of tumor from the anal verge (2.5 cm). 
5.4 Anorectal physiology 
An important goal of sphincter–preserving surgery is to reach acceptable quality of life 
levels by preserving fecal continence. The main concern of the ISR technique is functional 
outcome. Physiologic studies have shown that the anal resting pressure is 55% due to the 
IAS, 15% due the hemorrhoidal plexus and 30% due to the EAS (Sangwan & Sola, 1998). 
Total or partial excision of the IAS is bound to affect continence. Furthermore, preoperative 
radiation therapy may cause additional loss of sphincter function. Kohler et al reported a 29% 
reduction in resting anal pressure following ISR. Squeeze pressure recovered to preoperative 
levels after 12 months. Rullier et al compared outcomes in patients undergoing partial or 
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subtotal IAS resection. Subtotal excision of the sphincter was associated with significant 
reduction in resting but not squeeze pressure after ISR (Kohler et al., 2000; Rullier et al., 1999). 
5.5 Functional outcomes and quality of life 
Bretagnol et al reported that faecal continence measured by both the Kirwan and Wexner 
scores was significantly worse after ISR. In addition, the need for anti-diarrheal medication 
was higher in patients undergoing ISR compared with patients which had undergone 
conventional coloanal anastomosis (Bretagnol et al., 2004). 
Functional and continence score results were similar between patients undergoing partial 
ISR and total ISR. Frequency, urgency, the Wexner score and the Fecal Incontinence Severity 
Index (FISI) were shown to be significantly improved following colonic J-pouch 
reconstruction compared with straight coloanal anastomosis. 
Regarding quality of life (QOL), Bretagnol et al used both the SF-36 and the Fecal 
Incontinence Quality of Life (FIQL) to compare QOL between patients undergoing ISR and 
conventional coloanal anastomosis. There was no difference in the QOL scores between ISR 
patients and conventional coloanal anastomosis patients in the physical and mental 
subscales of the SF-36. 
Patients undergoing ISR with J-pouch reconstruction scored better in the domains of 
lifestyle, coping, depression and embarrassment at 3 months postoperatively but worse in 
the domain of embarrassment at the first postoperative year (Bretagnol et al., 2004). 
6. Local excision for rectal cancer 
Tepetes K, Pramateftakis MG, Spanos K 
Local excision (LE) seems to be an attractive therapeutic option because of the minor 
morbidity, short recovery time and excellent postoperative functional results. There is, 
however, a significant issue regarding the long term oncological results because of the 
limited ability of the technique in controlling regional disease. 
6.1 Indications 
The ideal candidates for LE should theoretically be:  
1. Low risk T1, T2 tumors 
2. Patients with significant co-morbidities unable to undergo a radical procedure 
3. Symptomatic patients with multi-organ distant metastatic disease  
4. Well informed patients denying a radical procedure or a stoma 
Generally, three approaches to local excision are reported: a) the transanal (conventional or 
Transanal Endoscopic Microsurgery), b) the transcoccygeal, and c) the transsphincteric. The 
transanal techniques have been customized for a long time throughout the world and for 
this reason they can be evaluated more reliably (Garcia-Aguilar et al., 2000). 
Factors associated with either the efficacy or the safety of the transanal excisions are the 
macroscopic and microscopic characteristics of the lesions.  
i. Macroscopic characteristics:  
1. T1, T2 lesions 
2. Lesions located within the distal 10-11 cm of the rectum 
3. Lesions smaller than 4 cm  
4. Lesions involving less than 40% of the lumen circumference. 
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ii. Microscopic characteristics:  
1. Tumor invasion (T): The local recurrence rate is strongly related to the depth of the 
initial mural invasion (T stage). It is not only the size of the tumor per se that makes 
the difference, but the lymph node involvement (N stage) as well, which is 
independently associated. T1 tumors have a 6-12% incidence of lymph node (LN) 
involvement, T2 tumors have positive lymph nodes (LNs) in 17-22% of the cases 
and T3 tumors have LN involvement in more than 66% of the cases. The 
aforementioned differences are reported to result in different 5-year local 
recurrence rates, namely 5% for T1 tumors, 18% for T2 tumors and 22-33% for T3 
tumors (Bouvet et al., 1999). 
2. Lymph node involvement (N): The LN involvement is not only associated with the 
T stage. Well or moderately differentiated T1 and T2 lesions may present with 
positive LNs in 14% of the cases and they may have a 5-year local recurrence rate of 
11%, whereas poorly differentiated same size tumors have positive LNs in 30% of 
the cases and a 5-year local recurrence rate of 33%. In addition, T1 and T2 tumors 
without vascular, lymphatic or perineural infiltration present positive LN stages in 
4-17%, in comparison with same size lesions with vascular, lymphatic of perineural 
infiltration which have LN positive disease in 31-33% of the cases. Finally, it is 
reported that mucinous rectal cancers have positive LN stage in 52% of the cases, in 
comparison with the non-mucinous tumors which have LN positive stage in 30% of 
the cases (Bayar et al., 2002). 
 
 
Fig. 5. Transanal excision of T1 lesion of the lower rectum. 
www.intechopen.com
 
Rectal Cancer - Staging and Surgical Approach 
 
73 
6.2 Recurrence & survival 
Local transanal excision of early rectal cancers (T1, T2) can be of value in well-informed 
patients. The locoregional recurrence rate for T1 tumors ranges from 4% to 29% and the 5-
year survival rate ranges from 83% to 100%. The best results are reported to be achieved in 
well-differentiated, non-mucinous, non-ulcerative lesions without vascular, lymphatic or 
perineural invasion and negative N staging. Quite often though, there are discrepancies in 
reported patient series with regards to patient selection criteria, staging protocols, surgical 
techniques, adjuvant treatment or length of follow-up. The length of follow-up is of 
paramount importance, especially in old patients carrying high co-morbidity. In addition, 
tumor recurrence can be seen later than 5 years postoperatively and 28% of rectal cancer 
deaths occur later than this time interval. Thus, 10-year survival following local excision for 
T1 and T2 tumors drops to 74% and 72% respectively and the 10-year local recurrence rate is 
17% to 26% (Chen et al., 2005; Garcia-Aguilar et al., 2000). 
There are no randomized trials comparing radical surgery (RS) to local excision, but there 
are comparative data from retrospective studies originated in specialized centres with 
regards to T1 rectal cancers. In these reports, recurrence rates following LE are 2-fold to 5-
fold higher. The cancer related survival rates of LE are also inferior to those of RS. The 
differences however are less prominent compared to those regarding recurrence, probably 
due to the short life expectancy of the older patients undergoing more often LE or ablative 
techniques. Another cause of discrepancy between groups is the proportion of patients 
undergoing salvage surgery in case of local recurrence. This rate varies significantly (50% to 
80%) and the 5-year survival rates present a similarly wide range (30% to 88%). The long 
term results in these cases are poorer than those following initial RS. More than 50% of 
salvage surgery cases require extended pelvic dissection due to the size and the extent of 
recurrent disease. Thus, 6-year survival rate is reported to be 30% compared with the 
average 5-year survival which is over 50%. Generally, it seems that less than 25% of patients 
who develop recurrence following LE are eventually cured (Endreseth et al., 2005; 
Mellegren et al., 2000). 
There is however a group of patients undergoing LE in the first place who can achieve 
survival and recurrence rates similar to those of patients undergoing initial RS. These are the 
patients who undergo early secondary radical resection (within 30 days following LE) 
because of high risk histological features in the excised specimens (positive margins, 
vascular invasion, etc.) The 5-year disease free survival of these patients is reported to reach 
94%. Therefore, LE as a sole therapeutic intervention is associated with considerable long-
term recurrence rates even for T1 rectal tumors. The main reason for these results seems to 
be the high incidence of regional LN metastases which may reach even 22% to 34% in T1 
rectal cancer overall, in comparison with 3% to 10% in T1 cancers of the rest large intestine. 
Therefore, it seems that in order to have improved results from LE, this method should be 
included in a multi-modality therapeutic strategy (Balch et al., 2006; Garcia-Aguilar et al., 
2000). 
6.3 The role of radio-chemotherapy 
The contribution of postoperative radiotherapy (RTx) following LE for T1 or T2 rectal 
tumors is difficult to be evaluated because of lack of large randomized trials and the large 
variation of reported doses (2,700-6,300 cGy) and techniques. The 5-year overall survival 
ranges from 67% to 80%, which lies close to survival following LE alone (Bittorf et al., 2003).  
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Fig. 6. Well-differentiated rectal tumor visible through the anal dilator during transanal 
resection.  
The fact that it is usually patients with high risk prognostic features that undergo 
postoperative RTx and the lack of randomization explain in part the absence of improved 
results. The local control rate following postoperative RTx however is reported to reach 96% 
at 5 years, dropping to 57% at 8 years. Perhaps postoperative RTx following LE does not 
alter the natural history of the disease per se, but it rather seems to delay locoregional 
recurrence by approximately 1 year (Kurt et al., 2005; Wagman et al., 1999). 
Preoperative radiotherapy or chemoradiation has been used to downstage rectal tumors and 
to facilitate sphincter-sparing surgery. In addition to the increased resectability of bulky 
rectal cancers, another benefit of neoadjuvant therapy seems to be the reduction of 
locoregional recurrence and the improved survival. It is reported that even T3N0 rectal 
cancer patients with complete clinical and pathologic response after neoadjuvant 
chemoradiation can achieve local recurrence and survival rates following LE equivalent to 
those following RS (Bonnem et al., 1999). The main limitation of suggesting conservative 
surgery for such patients is the accuracy of imaging methods (EUS, MRI) in restaging the 
original lesion, as well as the residual LN involvement following chemoradiation. Especially 
after radiotherapy, there is considerable difficulty to distinguish residual tumor and lymph 
node involvement from post radiation fibrosis. Nevertheless, 15-30% of patients seem to 
present reliable, complete clinical regression by endoscopic, imaging and serologic means, 
following neoadjuvant treatment (Mohiuddin et al., 2000).  
In addition, most of these patients will show complete pathologic response as well in RS 
specimens. Therefore, these patients (especially elderly ones) may have the same long term 
results after LE. The pathologic T-stage following neoadjuvant chemoradiation and LE (YPT 
stage) seems to be a strong predictor of residual LN disease (YpN stage). Patients with 
complete pathologic T regression (ypT0) have 0-24% risk for LN disease. In fact, there are 
small series reporting overall recurrence rates from 0% to 13% in patients with ypT0 and 
ypT1 lesions (Bedrosian et al., 2004; Marakis et al., 2009).  
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It seems that the advances in staging technology and methodology, as well as the adoption 
of modern neoadjuvant multimodality strategies may provide reliable conservative surgical 
treatment options. Carefully selected patients (e.g. elderly ones) undergoing local excision of 
early rectal cancer may have similar outcome with the ones following radical surgery, when 
the appropriate adjuvant or neo-adjuvant treatment is applied. 
7. Abdominoperineal resection for rectal cancer 
Papadopoulos V, Michalopoulos A, Pramateftakis MG 
In 1908, while investigating the pathogenesis of rectal cancer, Miles established the role of 
the lymphatic system in the spread of malignancy and emphasised the need for 
synchronous removal of the rectum and its “lymphatic drainage” with the 
abdominoperineal approach. Progress in medicine resulted in a decrease in post-operative 
deaths and allowed abdominoperineal resection (APR) to yield better long-term results as 
compared to trans-sacral procedures. 
7.1 Indications 
The question “Which patient with low rectal carcinoma is best treated by an APR?” has no 
simple answer. Many factors influence the decision to perform an APR for rectal cancer, as 
seen in Table 1. Surgeons have the responsibility to carefully weigh these factors, discuss all 
available options with the patient, and be knowledgeable and flexible in approaching those 
options individually for each patient (Rothenberger & Wang, 1992). 
 
Tumor-related Level from anal verge 
 Depth of invasion 
 Organ involvement 
 Unfavourable characteristics for local treatment 
 Metastases 
 
Patient-related Anal sphincter dysfunction 
 Pre-existing GI tract dysfunction (eg diarrheal syndromes) 
 Systemic diseases 
 Concomitant conditions indicating/contraindicating colostomy 
 Blindness 
 Severe arthritis 
 Mental incapacity 
 Paraplegia / Quadriplegia 
 Life expectancy 
 
Technique-related Inadequate clearance margins 
 Body habitus 
 Extended operation 
 Intraoperative complications 
Table 1. Factors that influence the decision of performing an APR. 
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The decision of the surgeon to reject sphincter-saving operations in favor of an APR should 
be based on a variety of variables, characteristic for the tumor and the patient. Therefore, the 
surgeon should make the final decision of operative technique upon completion of total 
mesorectal excision (TME), being certain of the absence of macro and microscopic evidence 
of cancer invasion in the circular and distal margin of expected resection (“rectum neck” in 
the area of junction to levator). An inadequacy of providing uninvaded margins can serve as 
an indication to perform APR. 
Invasion of the dentate line or a free margin less than 1 cm is also an indication for an 
APR. Digital rectal examination and rigid proctosigmoidoscopy are typically required for 
accurate tumour assessment. It is undeniable that cancer of the lower rectum can serve as 
an indication for APR when the parietal fascia is involved, as well as when there are 
symptoms of lymphatic spread, regardless of the distal margin of the tumour from the 
dentate line. 
 
 
Fig. 7. Specimen following abdominoperineal resection of the rectum. 
The variety of factors which can affect the surgeon’s decision whether to perform resection 
of the rectum should include the condition of the anal sphincters, bowel function, patient’s 
age, concomitant diseases and capability of self-care of stoma. Thus, in case of anal 
incontinence, for patients with adenocarcinoma located 1–2 cm from the dentate line, it is 
unreasonable to aim for intestine continuity, because incontinence can even deteriorate 
(Tsarkov, 2005). 
7.2 Contraindications 
Contraindications for the performance of APR include: 
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1. Low dimensional tumors (less than 2 cm in diameter) 
2. Tumors characterized by a high or good degree of differentiation 
3. Invasion of the tumor not exceeding the submucosal layer 
4. Absence of lymphovascular invasion. 
In all these cases it is reasonable to apply various other procedures such as transanal local 
excision, transanal endoscopic microsurgery, diathermocoagulation via anoscope, etc. At the 
same time, the T1 or T2 tumours without involvement of the internal sphincter and 
longitudinal muscle in case of well differentiated adenocarcinomas located 1–2 cm from the 
dentate line cannot be considered as an implicit indication for APR. These tumours should 
be judged from the viewpoint of the possibility of implementing resection of the rectum 
with subsequent formation of either ultralow stapled colorectal or hand-sutured colo-anal 
anastomosis. 
7.3 Postoperative care, complications and mortality 
Following pelvic dissection, there is some laxity of the anterior support as well as swelling 
and edema due to the procedure, which may lead to voiding difficulties in the first few 
days, particularly in male patients. The pelvic and abdominal drains are left in situ until 
they drain less than 50 ml daily. 
The operative mortality after an abdominoperineal resection should be less than 2%. As with 
all forms of major abdominal surgery, improved anesthesia techniques and invasive 
perioperative monitoring have allowed the reduction in mortality from 42% reported by Miles 
in 1908 (Chiappa et al., 2006; Peparini et al., 2006). Today, the majority of operative mortality 
in reported series is related to cardiopulmonary and septic complications. While mortality is 
relatively low, morbidity varies from 15% to 35% (Nissan et al., 2001; Piso et al., 2004).  
A prospective randomized trial demonstrated that laparoscopic-assisted APR offers better 
immediate outcomes in terms of faster return of bowel function, earlier mobilization and less 
analgesic requirements when compared with open surgery for low rectal cancer, but at the 
expense of longer operative times and higher cost. Oncological clearance and long-term 
survival are seemingly not jeopardized by the laparoscopic-assisted approach (Ng et al., 2008). 
After rectal cancer surgery, postoperative general complications occur in 20-35% of all 
patients and postoperative hospital stay is 5-7 days. “Fast-track” rehabilitation has been 
shown to accelerate recovery, reduce general morbidity and decrease hospital stay after 
elective rectal surgery (Schwenk et al., 2006). 
7.4 Complications of APR 
The potential benefit of surgery should be measured against the morbidity associated with 
pre-existing conditions not related to the primary disease and which may jeopardize the 
surgical outcome. Complications are related to the patient’s fitness, the operative procedure, 
surgical technique and anaesthesia. Therefore the surgeon’s role, besides careful patient 
selection and preoperative optimisation of pre-existing medical conditions, extends to a 
level of knowledge and technical skill that should minimise early and late complications 
(Tsarkov, 2005). 
7.4.1 Ureteric injury 
The ureters are prone to injury in any pelvic operation. Such injuries can occur during either 
the abdominal or perineal phase of an APR. Care should be taken to identify and protect the 
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ureters intra-operatively. During an APR for recurrent carcinoma and for very extensive 
rectal cancers, consideration may be given to the use of ureteric stents to aid the ureter 
identification. The incidence of ureteral injury in large published series has been variable. 
Eickenberg and colleagues reported ureteral obstruction in 7 out of 100 patients undergoing 
APR but could not distinguish whether this was due to intra-operative injury or other 
causes. The major morbidity from ureteric trauma is the unrecognized injury that presents 
later as an obstruction or fistula (Eickenberg et al., 1976). 
7.4.2 Compartment syndrome 
One of the concerns of placing the patient in the lithotomy position is its association with the 
development of a compartment syndrome. This occurs when elevated pressure in an osteo-
fascial compartment compromises local perfusion. This can result in neurovascular damage 
and permanent disability, emphasizing the importance of prevention and early diagnosis. 
Intermittent, sequential compression of the lower limbs is strongly encouraged to prevent 
venous stasis (Boulos & O’Bichere as cited in Hakim & Papalois, 2007). 
7.4.3 Abdominal Haemorrhage 
Haemorrhage is either primary or secondary. Primary bleeding at the time of surgery or in 
the immediate postoperative period is the result of poor surgical technique and the failure to 
achieve satisfactory haemostasis. Clotting disturbances due to massive transfusions and 
restoration of blood pressure with fluid replacement or drug therapy may be contributing 
factors. Secondary haemorrhage occurring 7–10 days after surgery is attributed to a 
dislodged blood clot, dissolution of ligature materials or erosion of a vessel due to an intra-
abdominal infection. 
7.4.4 Pelvic Haemorrhage 
In cases when there is locally advanced or recurrent cancer, previous pelvic surgery or pre-
operative radiotherapy, pelvic dissection of the rectum should be undertaken with extreme 
care. Rarely, a middle sacral artery over the sacral promontory or a left common iliac vein is 
injured at the start of the pelvic dissection. The lower pelvic side walls may cause significant 
bleeding when the pelvic fascia is pulled medially by fibrosis or tumour tethering leading to 
dissection outside the fascia that may injure the internal iliac vessels. Dissection along the 
correct plane is avascular down to the lateral ligaments which are then divided by clamping 
or ligation.  
Presacral haemorrhage is sometimes unavoidable when the presacral fascia (overlying the 
high pressure anterior venous plexus) is disrupted or if it is densely adhered to the 
mesorectal fat. Presacral haemorrhage can also occur from an injury to the anterior presacral 
plexus or the basivertebral veins during the placement of rectopexy sutures. Significant 
haemorrhage can occur if the basivertebral veins are divided at the level of the lower sacral 
foramina. These veins communicate with the internal vertebral venous system, a large 
valve-less venous system that communicates with the inferior vena cava. The rapid blood 
loss associated with this injury is related to high hydrostatic pressure in the depth of the 
pelvis accentuated in the lithotomy position, which increases venous pooling within the 
pelvis. In most instances bleeding can be controlled by packing, suture ligation, clips or 
cautery. These will be ineffective if the basivertebral veins are injured at the sacral foramina, 
due to the fact that these large veins tend to retract themselves into the sacral foramina 
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when injured. Bone wax or thumbtacks are employed to occlude the foramina and stop the 
bleeding (Boulos & O’Bichere as cited in Hakim & Papalois, 2007). 
7.4.5 Small bowel obstruction 
Mechanical bowel obstruction that occurs early in the postoperative period is commonly 
caused by fibrinous adhesions before they become organised by the invasion of fibroblasts 
and sprouting capillaries to form permanent fibrous adhesions. It is less frequently a result 
of internal herniation, volvulus, anastomotic edema, intraperitoneal haematoma or abscess.  
The appearance of a paralytic ileus is variable after abdominal surgery and is due to reflex 
inhibition of normal peristalsis. It is painless and lasts for a few days but is prolonged by 
visceral injury, abdominal sepsis or bleeding, immobility and some medications (atropine, 
ganglion blocking agents, diuretics). 
7.4.6 Genitourinary complications 
Other than operative trauma genitourinary complications comprise voiding and sexual 
dysfunction related to neurological damage during a pelvic dissection which might be 
unavoidable particularly in resections for advanced carcinomas. However with knowledge 
of the pelvic anatomy, surgical technique can be refined, exercising caution where nervous 
structures are particularly vulnerable, hence minimising the risk of these complications and 
improving the quality of life (Eickenberg et al., 1976; Tsarkov 2005). 
7.4.7 Bladder injuries & voiding dysfunction 
The bladder is exposed to injury during exploration via a lower incision of the abdomen or 
due to adhesions from previous surgery. An accidental cystotomy in the anterior surface of 
the bladder is easily repaired with two layers of continuous absorbable suture, and a urinary 
catheter is left in situ for 7 days. Injury to the posterior bladder wall can occur when 
mobilising an inflammatory or neoplastic recto-sigmoid mass or during perineal excision of 
the rectum. The repair of such an injury is more demanding, especially if the injury is at the 
base of the bladder. In that case, a urologist should be involved because of the risk of 
damaging the ureters during the repair. This can be carried out from inside the bladder 
through an anterior cystotomy, whereby ureteric stents are passed retrogradely to ensure 
their patency. 
Undetected injuries will manifest as a vesicoperineal fistula or an enterovesical fistula. 
Vesicoperineal fistulae are recognised by the leakage of urine through the perineal wound. 
The diagnosis is confirmed by a cystogram. Small fistulae may close with urethral or 
suprapubic catheter drainage for a minimum duration of 6 weeks. 
Urinary problems constitute the most frequent and troublesome complications following an 
APR. Urinary tract infections are very common, occurring in 6–32% of patients (Piso et al., 
2004). Contributing factors include the use of urinary catheters and urinary stasis. While 
bladder neck or prostate angulations may be contributory, the majority of micturition 
disturbances are due to neurologic injuries. As voiding dysfunction following an APR is 
common and transitory, one can expect it to subside within three to six months post-
operatively. 
Fowler et al warned that if large volume retention in the post-operative period secondary to 
bladder denervation is not recognised and remains untreated, bladder rehabilitation and 
restoration of normal voiding may be impossible. Many authors advocate the use of 
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urodynamic studies in order to identify patients at risk of developing urinary problems and 
to detect early post-operative voiding dysfunction (Fowler et al., 1978). 
Urinary dysfunction is of particular interest in the evaluation of the nerve-preserving 
procedure effectiveness. The parasympathetic nerve supply is responsible for bladder 
contraction. Furthermore, the sympathetic nerve supply allows relaxation of the bladder 
wall and contraction of the bladder neck while the perineal branch of the pudendal nerve 
supplies the external urethral sphincter. Early complications are recognised on removal of 
the urinary catheter and include urinary retention, infection and incontinence due to 
posterior bladder displacement after abdomino-perineal excision of the rectum, neurologic 
injury and pre-existing outlet obstruction precipitated by epidural anaesthesia, general 
anaesthesia, prolonged bed rest and alpha-agonist and anticholinergic medication. 
Recatheterisation, antibiotics, withdrawing drugs that contribute to urinary retention and a 
trial of alpha-adrenergic blockers are simple but often effective measures. 
Patients with urinary symptoms that continue for longer than 6 weeks after surgery should 
undergo urodynamic studies to determine the nature of the injury and differentiate it from a 
simple outlet obstruction requiring prostatectomy (Boulos & O’Bichere as cited in Hakim & 
Papalois, 2007; Eickenberg et al., 1976; Tsarkov 2005). 
7.4.8 Sexual dysfunction 
This is more common in males than females because of the anatomical relationship of the 
rectum to the nerves responsible for the sexual function and due to a better understanding 
of the male sexual response and disorders that follow pelvic surgery. Women suffer 
decreased libido, difficulty with orgasm and most commonly dyspareunia. Male 
dysfunction includes erectile difficulty, retrograde ejaculation and total impotence. Sexual 
dysfunction is more likely in patients of higher age and after resections for cancer than 
inflammatory bowel disease, due to the fact that dissection in this case is close to the rectal 
wall and perineal excision is performed in the intersphincteric plane. 
Male sexual dysfunction is regulated by the autonomic nervous system via the pelvic plexus 
which lies posterolateral to the bladder. Sympathetic nerves are responsible for ejaculation, 
while parasympathetic nerves govern erection. 15% of patients with normal sexual function 
prior to an APR are expected to experience some kind of sexual dysfunction (Boulos & 
O’Bichere as cited in Hakim & Papalois, 2007).  
7.4.9 Perineal complications 
Wound infections, perineal hernias, delayed healing and very rare chronic perineal sinuses 
are complications occurring at the perineal site. Only few patients require surgical 
intervention for such complications. Perineal wound infection is associated with closure 
rather than with open packing of the perineal wound especially when excision of the rectum 
is complicated by faecal contamination. Treatment consists of wound opening and local 
care. Nevertheless, the wound might not heal and if it remains unhealed for more than six 
months it is then defined as a perineal sinus. 
7.4.10 Stoma complications 
An array of stomal complications can occur in patients undergoing APR, as seen in table 2. 
The majority of these are preventable by careful attention to site selection and operative 
technique. Complications are more frequently encountered in unplanned stomas, in obese 
patients and in elderly patients. 
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Stoma complications Aetiology 
Ischemia / Necrosis Inadequate blood supply 
Excessive mesenteric stripping 
Haemorrhage Inadequate haemostasis 
Abscess formation Faecal spoilage / Haematoma 
Wall perforation by sutures 
Stoma retraction Excessive bowel tension 
Stenosis Ischaemia 
Inadequate skin aperture 
Parastomal hernia 
Prolapse 
Oversized abdominal wall aperture 
Inadequate fixation / repair 
Excessive stoma length 
Redundant sigmoid 
Table 2. Complications following stoma formation for APR. 
Skin problems such as skin irritation are usually the result of a flush or retracted stoma, an 
improperly placed stoma and allergy to adhesive materials on the bag. With strict hygiene, 
skin barriers and local antimicrobials the majority of these skin problems are easily 
manageable. A subcutaneous infection can lead to the formation of a fistula. The latter can 
be avoided by adjusting the size of the abdominal wall opening to the size of the bowel and 
by preserving the subcutaneous fat, in order to avoid creating dead space, prone to the 
formation of haematomas and infection. 
Necrosis is the result of skeletonization of the terminal bowel and inadequate abdominal 
wall opening particularly if the mesentery is thickened due to fat or inflammation. A colour 
change of a stoma is more likely to be due to ischaemia rather than to venous engorgement 
or submucosal haematoma if the stoma does not feel warm and there is no arterial ooze 
from the mucosa on pin-prick. The level of necrosis should be determined by examining the 
stoma with a paediatric proctoscope or a flexible endoscope as this guides further 
management. The long-term result of superficial necrosis is stenosis and the stoma can be 
revised by local exploration. Necrosis below the fascia, therefore intraperitoneally, requires 
immediate exploration via a laparotomy. Tension on the stoma, improper construction or 
ischaemia are responsible factors. An abdominal opening that is wider than the bowel 
lumen causes tension on the mucocutaneous sutures which break and the stoma separates 
itself from the skin. Stoma retraction may occur as a late complication if a patient gains 
excessive weight. 
Stenosis, often due to ischaemia, is a common cause of colostomy obstruction. The 
obstruction resolves spontaneously or by saline irrigation of the colostomy through a Foley 
catheter. Careful dilatation with the finger or graduated dilators can also be attempted in a 
stenosed stoma. If these measures fail to relieve obstruction, refashioning of the stoma is 
considered and this will probably require re-exploration, due to the fact that at this early 
stage local revision can be technically difficult and not safe due to inflammation and oedema 
at the stoma site. Stenosis identified at a later stage can be revised locally at least 3 months 
after the initial procedure, as fibrosis becomes established and the tissue planes are better 
defined to allow exteriorisation of a fresh segment of the bowel for fashioning of a new 
stoma.  
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Fig. 8. End colostomy following APR. 
A parastomal hernia is the commonest complication following stoma formation. 
Predisposing factors are obesity, chronic respiratory disease and a predisposition to other 
abdominal hernias. Ideally, the colostomy should be sited over the rectus muscle and 
brought out through the split thickness of the muscle. Parastomal herniation is less likely to 
occur if the stoma is fashioned through the muscle rather than at the side of the rectus 
muscle. Furthermore, the stoma should ideally be situated below the belt-line at a distance 
from the bony promontories and the umbilicus. Local repair may involve suture 
approximation of the defect with or without mesh reinforcement and if this fails, reciting of 
the stoma may become necessary.  
Colostomy prolapse is usually associated with a parastomal hernia, and is more common in 
obese patients. The prolapse, which is an intussusception of the proximal bowel, is easily 
reducible even by the patients themselves. Elective surgical treatment consists of excision of 
the redundant colon followed by local repair of the parastomal hernia (Boulos & O’Bichere 
as cited in Hakim & Papalois, 2007).  
7.5 Oncologic outcomes: Local recurrence & survival following APR 
Recent literature has shown that the local recurrence (LR) of lower rectal cancers is higher, 
compared to the middle and upper ones (Daniels et al., 2006). This may be due to a lack of 
mesorectum below the levator sling, which increases the chance of tumor spread to the 
perirectal tissues, increasing the risk of the surgical resection margin being invaded by tumor. 
In addition to that, low rectal cancers present with more significant factors that predict 
recurrence, such as lymphatic and vascular invasion, perineural invasion and positive nodal 
disease. Other factors are involvement of the circumferential resection margin (CRM), tumor 
distance from the anal verge, tumor differentiation, nodal status, extent of extramural spread 
and peritoneal perforation by the tumor (Birbeck et al., 2002; Hermanek et al., 1989). 
In Heald’s series, 45% of patients had cancers in the lower rectum. Of the patients who had a 
curative LAR, the 5-year LR rate was 7% and systemic recurrence rate was 27%, compared 
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with 17% and 27% in patients who had curative APR. The LR rate after an APR tends to be 
higher than for LAR in most series comparing rectal cancers of all stages, with a range of 10–
33% (Dehni et al., 2003). This comes in contrast with a LR rate of 4–8% for anterior resection 
with TME for all stages of rectal cancer, as reproduced by Enker in the USA (Enker et al., 1995). 
Studies by Quirke have shown that an involved CRM and the depth of extramural invasion 
are independent markers of poor prognosis and correlate with high LR rates due to residual 
microscopic disease. In patients with an involved CRM, the LR rate was 64%, compared 
with 9% in patients with a clear CRM (Quirke et al., 1988). Recent data suggests that a CRM 
at risk of tumor involvement can be accurately predicted on preoperative MRI. 
Marr et al examined the cause of LR and patient survival following APR and LAR for rectal 
carcinoma and the effect of TME (Marr et al., 2005). There was a significant difference in 
both LR rates (23.8% versus 13.5%, p=0.002) and cancer-specific 5-year survival (52.3% 
versus 65.8%, p=0.003) between the APR and LAR groups. The conclusion of the study was 
that patients treated by an APR have a higher rate of CRM involvement, a higher LR and 
poorer prognosis than LAR. The frequency of CRM involvement for an APR has not 
diminished with TME. CRM involvement in the APR specimens is related to the removal of 
less tissue at the level of the tumor. Where possible, a more radical operation should be 
considered for all low rectal cancer tumors. The high rates of LR following APR could be 
explained by a number of factors. APR may be associated with a different pattern of 
lymphatic spread, which is not included in the “tumor package” excised by TME, or 
inadequate surgical resection may occur in a higher proportion of patients (Marr et al., 
2005). Lymphatic spread to the iliac or obturator nodes occurs and removal of these nodes is 
reported as a determinant of LR. Inadequate excision appears to be the major factor 
determining outcome. 
In advanced extraperitoneal rectal cancer, Japanese surgeons perform a lateral pelvic nodal 
dissection with only partial pelvic autonomic nerve preservation. Most Western surgeons 
prefer the total mesorectal excision (TME) with complete pelvic nerve sparing except for the 
cases with evident neoplastic neural involvement. Another study was performed to identify 
long-term oncological results of the total nerve-sparing TME between LAR and APR. The 5-
year overall and disease-free survival rates were 88.8% and 77.7%, 90% and 75.1% and 62.3% 
and 45% for stage I, II and III respectively. The 8-year overall and disease-free survival rates 
were 77.7% and 77.7%, 78.3% and 75.1% and 50.4% and 40% for stage I, II and III 
respectively (Peparini et al., 2006). 
It has been shown that staging MRI can define the mesorectal fascia and its proximity to 
the tumor and thereby help identify the expected TME resection margin. This should be 
extended to early pT1/pT2 low rectal cancers with the possible addition of EUS. The 
identification of the proximity of the expected surgical CRM to the tumor in the low 
rectum is an important challenge to the radiologist in order to predict the likelihood of 
complete excision. pT3 low rectal cancers are unlikely to be completely excised by 
surgery, and either wider surgical excision with en bloc removal of the levators and anal 
sphincters or a reduction of the tumor size by preoperative radiochemotherapy is 
required. Over the last years, there is a trend towards accurate MRI staging and 
preoperative radio-chemotherapy. Adjustments to the treatment of low rectal cancer are 
urgently required to achieve the lower rates of involvement of the CRM that are now 
obtained following mesorectal excision for high and mid rectal excisions. This should 
greatly improve local recurrence rates and 5-year survival in patients with such disease 
(Christoforidis et al., 2004; Marr et al., 2005). 
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Another study was performed by den Dulk in order to identify tumor and patient related 
risk factors in patients with distal rectal cancer treated by an APR and associated with 
positive CRM, LR and overall survival. It is concluded that anterior tumor location, 
advanced T-stage, and higher N-stage were independent risk factors for positive CRM. 
Positive CRM, higher T-stage, and higher N-stage were risk factors for local recurrence. In 
addition to the risk factors for LR, distal tumor location and older age were associated with 
reduced overall survival (den Bulk et al., 2007). 
Preoperative chemoradiotherapy (CRT) has contributed remarkably to the increase of 
sphincter-preserving procedures (SPP) for lower rectal cancer. Kim et al compared the 
outcomes between APR and SPP after preoperative CRT in patients with locally advanced 
lower rectal cancer. Patients who underwent APR had a higher 5-year local recurrence 
(22.0% vs 11.5%, p=0.028) and lower 5-year cancer-specific survival rate (52.9% vs 71.1%, 
p=0.03) compared to patients who underwent SPP. This study shows that APR following 
preoperative CRT exhibited more adverse oncologic outcomes compared to SPP. This result 
may be due to higher rates of CRM involvement in APR even following preoperative CRT. 
The authors suggest that sharp perineal dissection and wider cylindrical excision at the level 
of the anorectal junction are required to avoid CRM involvement and improve oncologic 
outcomes in patients who undergo APR following preoperative CRT (Kim et al., 2009). 
With regards to whether specific histopathological parameters can predict local recurrence, 
Dresen et al studied TxNxM0 patients treated for locally recurrent rectal cancer over a period of 
12 years. These patients were matched with a control group of patients who did not develop 
LR after primary rectal cancer treatment for at least 2 years based on the type of neoadjuvant 
treatment in an 1:2 ratio. The pathology of all primary rectal cancers was reviewed. Patient, 
treatment and histopathological characteristics were studied in relationship with the 
development of LR. The results indicate that the presence of lymphovascular invasion (LVI), 
extramural venous invasion (EMVI), positive CRM, serosal involvement and poor 
differentiation are factors leading to an increased risk of LR. However, higher age was a 
protective factor. The study concluded that apart from a positive CRM and serosal 
involvement, LVI, EMVI and poor differentiation are important independent predictive factors 
for the development of LR. Adjuvant therapy may be considered in the presence of these 
features in order to decrease the risk of a local recurrence (Dresen et al., 2009). 
Laparoscopic resection for rectal cancer is feasible and safe, with acceptable morbidity and 
long-term results in patients receiving neoadjuvant treatment. In a study by Pugliese et al, 
the 5-year survival rate was 74.6% after laparoscopic LAR and 53% after laparoscopic APR 
(Pugliese et al., 2009). Baek et al, in an effort to evaluate oncologic outcomes after robotic-
assisted LAR and APR with TME, analyzed prospectively sixty-four consecutive rectal 
cancer patients with stage I-III disease. The study showed that the CRM was negative in all 
surgical specimens, no port-site recurrence occurred in any patient and 6 patients developed 
recurrence: 2 combined local and distant, and 4 distal alone (mean follow-up of 20.2 
months). None of the patients developed isolated local recurrence. The mean time to local 
recurrence was 23 months and 3-year overall and disease-free survival rates were 96.2% and 
73.7%, respectively (Baek et al., 2010; Kanellos D et al., 2010). 
7.6 Functional outcomes and quality of life 
Avoiding a permanent stoma following rectal cancer excision is believed to improve quality 
of life (QoL), but evidence from comparative studies is contradictory. The results of a meta-
analysis comparing QoL following APR with that after LAR in patients with rectal cancer 
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show that the argument for restorative resections for rectal cancer cannot hinge solely on the 
issue of a perception of superior QoL outcomes for patients. It is clear that the preconception 
of many surgeons and patients is that QoL will be better if a permanent stoma is avoided. To 
the contrary, patients undergoing APR experience postoperatively a global QoL - 
incorporating the physical and psychological effects of treatment with or without a 
permanent stoma - that appears to be equivalent to that after LAR. Overall measures of QoL, 
measured using a variety of validated tools, are not significantly different between APR and 
LAR patients, but further comparative studies with longer periods of follow-up are needed. 
Individual domains do highlight significant differences between the two surgical 
approaches which may help the preoperative decision making process, but individualisation 
of care incorporating QoL outcomes and functional, oncological and technical 
considerations is essential for rectal cancer patients (Cornish et al., 2007). 
Emotional and cognitive scores from the QLQ C30 questionnaire were consistently shown to 
be better for APR patients, while physical function was shown to be better for LAR patients 
using both tools. The improved emotional scores for APR patients may represent the finality 
of the treatment, as a patient no longer needs to be concerned about invasive examinations 
of the lower GI tract or worry about future complications once healed adequately. 
While some authors have reported that functional recovery following LAR is complete by 
the 6th postoperative month, others have suggested that at 1 year following LAR, stool 
frequency is still significantly higher than that preoperatively and that the so-called 
“anterior resection syndrome” lasts for at least 1 year (Kakodkar et al., 2006). 
The decision of which operation to perform would depend on a number of variables, 
including the likely oncological outcome, the life expectancy of the individual patient and 
their attitude towards a permanent stoma. There is evidence to suggest that oncological 
outcomes such as circumferential resection margins and rates of local recurrence are less 
favourable following APR than LAR. Such results may reflect technical factors that render 
APR a more complex procedure or differences in anatomy and tumour biology that may 
negatively impact on lower rectal tumours, which are more likely to be treated with 
sphincter-sacrificing surgery. In some cases, however, the height of the lesion will 
necessitate APR, as even ultra-low LAR with inter-sphincteric dissection will be inadequate 
to permit a safe oncological excision (Tekkis et al., 2005). 
The overall findings of the meta-analysis by Cornish et al, highlighting no overall difference 
in QoL between those patients with and without permanent stomas, challenge the 
conclusions that may be drawn from other reports which have highlighted rates of stoma-
related complications of up to 34%, with deterioration in overall lifestyle and sexual activity 
by 80% and 43%, respectively. Meta-analyses of individual domains from the QoL 
instruments suggested improved cognitive, emotional and future perspective scores for 
those undergoing APR (Cornish et al., 2007). 
8. Treatment algorithm for cancer of the rectum 
Pramateftakis MG, Spanos K, Tepetes K 
Treating rectal cancer certainly requires a multidisciplinary approach involving surgery, 
radiology, pathology and oncology. Even though chemoradiotherapy has made huge 
advances over the last years, especially in the form of neoadjuvant therapy, radical surgery 
and lymphatic clearance remain the key elements to treating rectal cancer. It is therefore 
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crucial to say that designing a treatment plan should be “individualised” to each patient, 
depending on location and stage of the disease (Kanellos et al., 2010). 
Pre-operative tumor staging will determine the tumor stage. Depending on the T stage of 
the cancer, three treatment categories can be identified: The early stage, the intermediate 
stage and the advanced stage cancer. The treatment approach one should follow is shown in 
Table 3: 
 
Cancer stage Treatment 
Early cancer (T1) Local transanal resection / Radical resection 
Intermediate cancer (T2) 
Radical resection followed by adjuvant 
chemo-radiotherapy (depending on N status) 
Advanced cancer (T3,T4) 
Neo-adjuvant chemo-radiotherapy followed 
by major radical resection 
Table 3. Treatment according to stage. 
After the decision on the treatment plan has been made, the surgeon has to decide on his 
approach to the tumor. The position of the tumor with regards to the dentate line plays a 
significant role in the approach chosen by the surgeon, a fact that was analyzed in detail in 
the previous chapters. Therefore, depending on the tumor distance from the dentate line, 
four treatment categories can be identified. These are shown in Table 4: 
 
Distance Stage Approach 
≥4-5 cm from dentate line T1-T4 Low anterior resection 
<4 cm from dentate line 
T1 (well-differentiated, 
<3 cm diameter) 
Transanal resection 
1-3 cm from dentate line 
T1 or T2 with “un-
favourable” characteristics 
Intersphincteric resection 
0-3 cm from dentate line 
T3-T4 Abdominoperineal 
resection 
Table 4. Treatment according to location. 
9. Conclusion 
Pramateftakis MG 
In order to be successful in treating rectal cancer, good oncologic outcome is the first 
priority. Equally important is the achievement of an acceptable quality of life for the patient. 
The avoidance of a permanent stoma, with all of the concomitant morbidity associated with 
it, may be of greater importance to the patient. 
Despite advances in surgical technique along with improvements in neoadjuvant and 
adjuvant therapy, the surgical treatment of rectal cancer involving the pelvic floor and 
sphincter complex remains complicated. The decision on the type of surgery to perform 
depends on a number of variables including stage of the disease, tumour characteristics, 
condition of the anal sphincter mechanism, bowel function, patient’s age, concomitant 
diseases, life expectancy and capability of stoma self-care. 
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Why are survival rates worse after abdominoperineal resections compared to low anterior 
resections? Patients with very low rectal cancer treated by an APR have worse tumor 
characteristics and higher involved margin rates compared to patients treated by LAR. 
Furthermore, they have more locally extensive tumors despite a greater proportion 
undergoing neoadjuvant treatment. Patients with low rectal cancer pose difficulties with 
regards to optimal management. Targeted strategies are needed to improve outcome in this 
complex and common cancer. 
Careful patient selection, high quality preoperative imaging and functional assessment, with 
emphasis on sound operative technique should lead to superior results. 
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